Menu

Bertozzi the Editor

Stanford University biochemist Carolyn Bertozzi discusses her role at the helm of ACS Central Science, a cross-disciplinary, open-access chemistry journal

Jun 1, 2016
The Scientist Staff
Glycan chemist Carolyn Bertozzi discusses her role as journal editor in chief.
Carolyn Bertozzi:  We work at the interface of chemistry and biology, and our mission is to develop chemical tools that allow us to study biological processes in new ways, and this has given us insight into how various diseases work and how we might treat them.  We're very interested in cancer and being able to detect cancer at early stages and identify pathways that we can interrupt that might stop the growth of cancer cells. When ACS first approached me with the idea for ACS Central Science, it immediately resonated with some of the issues that I feel are very important in chemistry and in society.  Our challenge is to create a publishing house that basically collects the most exciting high impact work across both chemistry and allied disciplines and bring it together in a way that's accessible, readable, open, welcoming, inclusive.  That's what we can achieve. Because we have no subscription charges, no author charges, this means people can get into this journal at any time from any place.  The barriers to access have been eliminated, and this is I think a trend that major publishing houses are considering and following.  But, ACS is taking a leadership role. If we can use this journal as a vehicle to elevate the visibility of chemistry as the central science, not just amongst chemists—I think most of us are already in agreement with that—but amongst scientists outside of chemistry, amongst people in the population outside of the sciences. Aand again, this is what open access allows you to do. Even 10 to 15 years ago, there was a misconception of open access journals as a place where people just submit the article that could not get accepted anywhere else.  Nowadays, people understand that open access publishing is a social responsibility. As more scientists start to understand the social responsibility of publishing in open access journals, I think what we'll find is that competition to have one's articles accepted in ACS Central Science becomes quite fierce. Our goal at ACS Central Science is to publish work at the leading edge of discovery in fundamental chemistry, but at the same time, we hope to publish interdisciplinary science that showcases the centrality of chemistry.  We're hoping to get articles that are of broad interest, that are accessible to a broad

Read the full story.

April 2019

Will Car T Cells Smash Tumors?

New trials take the therapy beyond the blood

Marketplace

Sponsored Product Updates

Getting More Consistent Results by Knowing the Quality of Your Protein
Getting More Consistent Results by Knowing the Quality of Your Protein
Download this guide from NanoTemper to learn how to identify and evaluate the quality of your protein samples!
Myth Busting: The Best Way to Use Pure Water in the Lab
Myth Busting: The Best Way to Use Pure Water in the Lab
Download this white paper from ELGA LabWater to learn about the role of pure water in the laboratory and the advantages of in-house water purification!
Shimadzu's New Nexera UHPLC Series with AI and IoT Enhancements Sets Industry Standard for Intelligence, Efficiency and Design
Shimadzu's New Nexera UHPLC Series with AI and IoT Enhancements Sets Industry Standard for Intelligence, Efficiency and Design
Shimadzu Corporation announces the release of the Nexera Ultra High-Performance Liquid Chromatograph series, incorporating artificial intelligence as Analytical Intelligence, allowing systems to detect and resolve issues automatically. The Nexera series makes lab management simple by integrating IoT and device networking, enabling users to easily review instrument status, optimize resource allocation, and achieve higher throughput.
IDT lowers genomic barriers with powerful rhAmpSeq™ targeted sequencing system
IDT lowers genomic barriers with powerful rhAmpSeq™ targeted sequencing system
Increasing accuracy and reducing cost barriers, IDT’s innovative system delivers simple and cost-effective amplicon sequencing